Publications

2025

1. 

   GEPIA3: Enhanced drug sensitivity and interaction network analysis for cancer research

   Yu-Jian Kang^*, Lingjie Pan^*, Yiyu Liu^*, Zhengqin Rong, Jiaxi Liu, and Fenglin Liu^†

   Nucleic Acids Research, Jul 2025 2024 IF 13.1 JCR Q1

   Link Abs PDF PubMed

   

   GEPIA3 extends the GEPIA platform for pan-cancer analysis with drug sensitivity, interaction network, and RNA alteration modules. It integrates patient cohorts, cancer cell line screens, and multi-omics resources to support biomarker discovery and therapeutic target exploration.